Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women

NCT07057310 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Menopause

Interventions

DRUG: semaglutide or tirzepatide
BEHAVIORAL: Lifestyle modification intervention

Sponsor

Mayo Clinic